← Open Payments lookup

EDWIN CUEVA: Open Payments

NPI 1952319261 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,014 in 172 payments from 14 companies in 2025. Trend: 2023 $4,285 · 2024 $3,765 · 2025 $5,014

Food & beverage: $4,999Education: $15
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.24$902
Vanda Pharmaceuticals Inc.26$821
Axsome Therapeutics, Inc.24$722
Otsuka America Pharmaceutical, Inc.29$678
Alkermes, Inc.13$538
ABBVIE INC.17$358
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$341
Lundbeck LLC15$275
Neurocrine BioSciences, Inc.1$114
Teva Pharmaceuticals USA, Inc.4$94

Products named: COBENFY, Auvelity, REXULTI, HETLIOZ, FANAPT, VRAYLAR, CAPLYTA, VIVITROL.

Industry payments across NY — which companies pay providers there.